SI1951290T1 - A device for use in the case of fructose intolerance - Google Patents
A device for use in the case of fructose intolerance Download PDFInfo
- Publication number
- SI1951290T1 SI1951290T1 SI200632244T SI200632244T SI1951290T1 SI 1951290 T1 SI1951290 T1 SI 1951290T1 SI 200632244 T SI200632244 T SI 200632244T SI 200632244 T SI200632244 T SI 200632244T SI 1951290 T1 SI1951290 T1 SI 1951290T1
- Authority
- SI
- Slovenia
- Prior art keywords
- fructose
- dehydrogenase
- use according
- fructose dehydrogenase
- intolerance
- Prior art date
Links
- 206010072104 Fructose intolerance Diseases 0.000 title claims abstract 9
- 206010019878 Hereditary fructose intolerance Diseases 0.000 title claims abstract 9
- 239000003795 chemical substances by application Substances 0.000 title abstract 4
- 101710088194 Dehydrogenase Proteins 0.000 claims abstract 27
- 229930091371 Fructose Natural products 0.000 claims abstract 8
- 239000005715 Fructose Substances 0.000 claims abstract 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract 8
- 241001465754 Metazoa Species 0.000 claims abstract 4
- 108700040099 Xylose isomerases Proteins 0.000 claims abstract 4
- 239000000126 substance Substances 0.000 claims abstract 4
- 102000016679 alpha-Glucosidases Human genes 0.000 claims abstract 2
- 108010028144 alpha-Glucosidases Proteins 0.000 claims abstract 2
- 108010051210 beta-Fructofuranosidase Proteins 0.000 claims abstract 2
- 235000011073 invertase Nutrition 0.000 claims abstract 2
- 239000001573 invertase Substances 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 230000003247 decreasing effect Effects 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 102000027487 Fructose-Bisphosphatase Human genes 0.000 claims 1
- 108010017464 Fructose-Bisphosphatase Proteins 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/52—Isomerases (5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01124—Fructose 5-dehydrogenase (NADP+) (1.1.1.124)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/0102—Alpha-glucosidase (3.2.1.20)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01026—Beta-fructofuranosidase (3.2.1.26), i.e. invertase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01005—Xylose isomerase (5.3.1.5)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005055081 | 2005-11-16 | ||
| DE102005056169 | 2005-11-23 | ||
| DE102005060768 | 2005-12-16 | ||
| DE102005060769 | 2005-12-16 | ||
| DE102006000881 | 2006-01-04 | ||
| DE102006000873 | 2006-01-04 | ||
| DE102006001015 | 2006-01-05 | ||
| US75742406P | 2006-01-10 | 2006-01-10 | |
| US75741406P | 2006-01-10 | 2006-01-10 | |
| DE102006012244A DE102006012244A1 (de) | 2005-11-16 | 2006-03-15 | Mittel zur Anwendung bei Fructoseintoleranz |
| DE102006013624A DE102006013624B4 (de) | 2005-11-23 | 2006-03-22 | Mittel zur Anwendung bei Fructoseintoleranz |
| DE102006014423 | 2006-03-27 | ||
| US83117406P | 2006-07-17 | 2006-07-17 | |
| US83105006P | 2006-07-17 | 2006-07-17 | |
| EP06820896.6A EP1951290B1 (en) | 2005-11-16 | 2006-11-15 | Agent for use in the case of fructose intolerance |
| PCT/IB2006/003223 WO2007057749A2 (en) | 2005-11-16 | 2006-11-15 | Agent for use in the case of fructose intolerance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1951290T1 true SI1951290T1 (en) | 2018-04-30 |
Family
ID=38049014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200632244T SI1951290T1 (en) | 2005-11-16 | 2006-11-15 | A device for use in the case of fructose intolerance |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20090081300A1 (https=) |
| EP (2) | EP1951290B1 (https=) |
| JP (1) | JP2009519897A (https=) |
| KR (1) | KR20080080122A (https=) |
| AU (1) | AU2006314188B2 (https=) |
| CA (1) | CA2669431C (https=) |
| CY (1) | CY1119940T1 (https=) |
| HR (1) | HRP20180327T1 (https=) |
| IL (1) | IL191363B (https=) |
| PL (1) | PL1951290T3 (https=) |
| SI (1) | SI1951290T1 (https=) |
| WO (1) | WO2007057749A2 (https=) |
| ZA (1) | ZA200805143B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1951289B1 (en) * | 2005-11-23 | 2018-11-14 | Pro Natura Gesellschaft für Gesunde Ernährung mbH | Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
| AU2013211517B2 (en) * | 2005-11-23 | 2016-06-30 | Pro Natura Gesellschaft Fur Gesunde Ernahrung Mbh | Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
| DE102007008664B4 (de) * | 2007-02-20 | 2021-07-29 | Vitacare Gmbh & Co. Kg | Mittel zur Anwendung bei Fructoseintoleranz |
| EP2161034A1 (de) | 2008-09-04 | 2010-03-10 | Sciotec Diagnostic Technologies GmbH | Behandlung von Fruktose-Malabsorption |
| EP2340035B1 (de) | 2008-09-04 | 2014-07-16 | Sciotec Diagnostic Technologies GmbH | Behandlung von fruktose-malabsorption |
| WO2010107414A1 (en) * | 2009-03-19 | 2010-09-23 | Amano Enzyme Inc. | Enzyme compositions and use thereof |
| EP3415631A1 (en) * | 2017-06-13 | 2018-12-19 | RWTH Aachen | Methods of producing 5-ketofructose |
| JP7469332B2 (ja) * | 2019-05-13 | 2024-04-16 | サミ－サビンサ グループ リミテッド | フルクトフィリック乳酸産生細菌 |
| CN112536005B (zh) * | 2020-11-05 | 2022-05-03 | 华南理工大学 | 一种淀粉包埋香气物质微胶囊及其制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107291A (en) * | 1969-06-05 | 1978-08-15 | Sankyo Company Limited | Compositions for cleaning teeth and oral cavity |
| US4396602A (en) * | 1981-09-22 | 1983-08-02 | Asahi Kasei Kogyo Kabushiki Kaisha | Blood glucose level lowering agents |
| DK8502857A (https=) * | 1984-06-25 | 1985-12-26 | ||
| JPS6236191A (ja) * | 1985-08-09 | 1987-02-17 | House Food Ind Co Ltd | 固定化酵素の製造方法 |
| SE8505783D0 (sv) | 1985-12-06 | 1985-12-06 | Rolf Bergkvist | Forfarande for framstellning av livsmedelsprodukter och dessas anvendning |
| JPH0640824B2 (ja) * | 1987-03-19 | 1994-06-01 | 東洋紡績株式会社 | 安定なフラクト−スデヒドロゲナ−ゼ組成物 |
| US5068110A (en) * | 1987-09-29 | 1991-11-26 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
| US6165500A (en) * | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
| FI905402A7 (fi) | 1990-11-01 | 1992-05-02 | Alko Ab Oy | Oligosakkaridiseos ja menetelmä sen jälkikäsittelyksi |
| US5650156A (en) * | 1993-02-22 | 1997-07-22 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of nutriceuticals and compositions useful therefor |
| US5759539A (en) * | 1995-06-06 | 1998-06-02 | Georgia Research Foundation, Inc. | Method for rapid enzymatic alcohol removal |
| US6057139A (en) * | 1995-06-29 | 2000-05-02 | Mcneil-Ppc, Inc. | Preblend of microcrystalline cellulose and lactase for making tablets |
| CA2294525A1 (en) * | 1997-06-17 | 1998-12-23 | Monsanto Company | Expression of fructose 1,6 bisphosphate aldolase in transgenic plants |
| AU740108B2 (en) | 1997-06-17 | 2001-11-01 | Novozymes A/S | An oral care composition comprising a bacillus pullulanase and a dextranase |
| AU762967B2 (en) * | 1998-05-13 | 2003-07-10 | Novozymes A/S | Methods for using dehydrogenases in baking |
| CA2328137A1 (en) * | 1998-05-29 | 1999-12-09 | Novo Nordisk A/S | Methods for using xyloglucan endotransglycosylase in baking |
| US6042823A (en) | 1998-07-02 | 2000-03-28 | Amano Pharmaceuticals Co., Ltd. | Enzyme composition and use thereof |
| US7767203B2 (en) * | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| JP2000125883A (ja) * | 1998-10-21 | 2000-05-09 | Internatl Reagents Corp | フルクトキナーゼ及びその遺伝子 |
| AU6326699A (en) | 1998-11-05 | 2000-05-29 | Novozymes A/S | Methods for using a glucose isomerase in baking |
| IL138990A0 (en) * | 1999-02-12 | 2001-11-25 | Biostream Inc | Matrices for drug delivery and methods for making and using the same |
| EP1203822A1 (en) * | 2000-11-02 | 2002-05-08 | Societe Des Produits Nestle S.A. | Extracellular polysaccharide from Gluconacetobacter spp |
| US6754884B1 (en) | 2001-07-02 | 2004-06-22 | Bea Systems, Inc. | Programming language extensions for processing XML objects and related applications |
| JP4824886B2 (ja) * | 2001-09-11 | 2011-11-30 | 長岡香料株式会社 | フルクトース吸収阻害剤、組成物、および食品 |
| US20030113310A1 (en) * | 2001-12-17 | 2003-06-19 | Van Laere Katrien Maria Jozefa | Method for the treatment of obesity, overweight and fluctuations in blood insuline and/or glucose levels |
| ES2533469T3 (es) * | 2002-10-11 | 2015-04-10 | Novozymes A/S | Método de preparación de un producto tratado con calor |
| JP2004261174A (ja) * | 2003-02-13 | 2004-09-24 | Fujicco Co Ltd | 豆乳発酵物およびそれを用いた飲食品 |
| WO2004079848A2 (en) | 2003-03-03 | 2004-09-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Novel electrode with switchable and tunable power output and fuel cell using such electrode |
| JPWO2006004106A1 (ja) * | 2004-07-05 | 2008-04-24 | マルキンバイオ株式会社 | ザクロ果汁、ザクロ果汁粉末及び該粉末の製造方法 |
| EP1951289B1 (en) * | 2005-11-23 | 2018-11-14 | Pro Natura Gesellschaft für Gesunde Ernährung mbH | Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
-
2006
- 2006-11-15 PL PL06820896T patent/PL1951290T3/pl unknown
- 2006-11-15 JP JP2008540716A patent/JP2009519897A/ja active Pending
- 2006-11-15 EP EP06820896.6A patent/EP1951290B1/en active Active
- 2006-11-15 KR KR1020087014569A patent/KR20080080122A/ko not_active Withdrawn
- 2006-11-15 AU AU2006314188A patent/AU2006314188B2/en not_active Ceased
- 2006-11-15 HR HRP20180327TT patent/HRP20180327T1/hr unknown
- 2006-11-15 SI SI200632244T patent/SI1951290T1/en unknown
- 2006-11-15 WO PCT/IB2006/003223 patent/WO2007057749A2/en not_active Ceased
- 2006-11-15 EP EP17195181.7A patent/EP3318271A1/en not_active Withdrawn
- 2006-11-15 CA CA2669431A patent/CA2669431C/en not_active Expired - Fee Related
- 2006-11-15 US US12/093,822 patent/US20090081300A1/en not_active Abandoned
-
2008
- 2008-05-12 IL IL191363A patent/IL191363B/en active IP Right Grant
- 2008-06-12 ZA ZA2008/05143A patent/ZA200805143B/en unknown
-
2012
- 2012-11-12 US US13/674,841 patent/US9446101B2/en not_active Expired - Fee Related
-
2016
- 2016-09-19 US US15/269,943 patent/US10568942B2/en active Active
-
2018
- 2018-02-22 CY CY20181100218T patent/CY1119940T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20180327T1 (hr) | 2018-04-06 |
| WO2007057749A3 (en) | 2008-10-16 |
| US20090081300A1 (en) | 2009-03-26 |
| ZA200805143B (en) | 2012-02-29 |
| AU2006314188A1 (en) | 2007-05-24 |
| KR20080080122A (ko) | 2008-09-02 |
| IL191363B (en) | 2018-05-31 |
| EP3318271A1 (en) | 2018-05-09 |
| US20180344818A1 (en) | 2018-12-06 |
| CA2669431C (en) | 2019-04-23 |
| EP1951290B1 (en) | 2017-12-27 |
| CY1119940T1 (el) | 2018-12-12 |
| JP2009519897A (ja) | 2009-05-21 |
| PL1951290T3 (pl) | 2018-05-30 |
| WO2007057749A2 (en) | 2007-05-24 |
| CA2669431A1 (en) | 2007-05-24 |
| US10568942B2 (en) | 2020-02-25 |
| EP1951290A2 (en) | 2008-08-06 |
| US9446101B2 (en) | 2016-09-20 |
| AU2006314188B2 (en) | 2014-01-16 |
| US20130224171A1 (en) | 2013-08-29 |
| EP1951290A4 (en) | 2009-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2909456T3 (es) | Métodos para tratar el trastorno del espectro autista y síntomas asociados | |
| CN105120847B (zh) | 益生生物和/或治疗剂的靶向胃肠道递送 | |
| US20160129053A1 (en) | Methods of isolating microorganisms and uses thereof | |
| US20180000743A1 (en) | Modified Alginate Hydrogels for Therapeutic Agents, their Preparation and Methods Thereof | |
| HUE035426T2 (hu) | Probiotikus és prebiotikus komponenseket és ásványi sókat tartalmazó készítmények laktoferrinnel | |
| US20160287679A1 (en) | Pharmaceutical preparation | |
| WO2001041785A3 (en) | Enzyme treatment for infection | |
| US20240016748A1 (en) | Direct delivery of vitamins to inhibit microbial pathogens | |
| KR101790666B1 (ko) | 애완동물용 구강용해필름 | |
| SI1951290T1 (en) | A device for use in the case of fructose intolerance | |
| US10766970B2 (en) | Modified carbohydrates, compositions comprising the same, and methods of making and using the same | |
| JP2010511039A5 (https=) | ||
| US11116809B2 (en) | Biopolymer compositions for the treatment and prevention of liver disease | |
| CN114585380A (zh) | 胃肠健康组合物 | |
| TW200600121A (en) | Pharmaceutical dosage forms | |
| CN104288181B (zh) | 一种治疗宠物因驱虫导致不舒的膏剂及其制备方法 | |
| JP2009519897A5 (https=) | ||
| JPWO2014119605A1 (ja) | ビフィズス菌を含有する安定な組成物 | |
| US9308243B2 (en) | Cellular enhancements in biological systems through the use of li-pofullerene and peptide group combinations | |
| Baheti et al. | Different formulation approaches to improve the survivability of probiotics in the digestive tract | |
| EP3478725B1 (en) | Modified carbohydrates, compositions comprising the same, and methods of making and using the same | |
| JP2010248219A (ja) | 生活の質を改善する新規医薬組成物ならびに新規食品の製法および用途 | |
| Zhang et al. | Evaluating the effect of food components on the digestion of dietary nucleic acids in human gastric juice in vitro | |
| KR20150141943A (ko) | 장 손상 및 밀착연접 기능장애 관련 질병의 치료 및 예방을 위한 방법 및 조성물 | |
| CN107405367A (zh) | 消化性溃疡的预防或治疗剂、用于预防或治疗消化性溃疡的食品添加物、iNOS表达抑制剂及COX‑2表达抑制剂 |